Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine in clinical practice and the issues involved

被引：0
|
作者：
Bradshaw, H. [1 ]
机构：
[1] Singleton Hosp, Swansea, W Glam, Wales
来源：
HIV MEDICINE | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P114
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [41] Pre-Exposure Prophylaxis (PrEP): NYC Implementation Strategy
    Daskalakis, Demetre
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 28 - 28
  • [42] Tenofovir-based HIV pre-exposure prophylaxis
    Paxton, Lynn A.
    FUTURE VIROLOGY, 2013, 8 (12) : 1207 - 1218
  • [43] State of the Science - HIV Pre-Exposure Prophylaxis (PrEP)
    Chariyalertsak, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E9 - E10
  • [44] TRUVADA AS PRE-EXPOSURE PROPHYLAXIS (PREP): ONE SITE'S CLINICAL EXPERIENCES
    Straub, Diane M.
    Berger, Terri
    Cruz, Freddy
    JOURNAL OF ADOLESCENT HEALTH, 2017, 60 (02) : S81 - S82
  • [45] A Subcutaneous Biodegradable Implant for Sustained Delivery of Tenofovir Alafenamide (TAF) for HIV Pre-exposure Prophylaxis (PrEP)
    Girouard, Natalie
    Johnson, Leah
    Luecke, Ellen
    Demkovich, Zach
    Jester, Teresa
    Li, Alice
    Johnson, Pafio
    van der Straten, Ariane
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 107 - 107
  • [46] HIV pre-exposure prophylaxis (PrEP); [Pre-expositieprofylaxe tegen hiv (PrEP)]
    Hermanussen R.
    Huisarts en wetenschap, 2017, 60 (6) : 264 - 267
  • [47] HERPES SIMPLEX VIRUS (HSV) INFECTION IN THE VOICE (MTN 003) STUDY: PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV WITH DAILY USE OF ORAL TENOFOVIR, ORAL TENOFOVIR-EMTRICITABINE, OR VAGINAL TENOFOVIR GEL
    Marrazzo, J.
    Rabe, L.
    Kelly, C.
    Livant, T.
    Chirenje, M.
    Richardson, B.
    Deal, C.
    Piper, J.
    Hillier, S.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A46 - A46
  • [48] Failure of pre-exposure prophylaxis with on-demand tenofovir disoproxil fumarate/emtricitabine resulting in emergence of antiretroviral resistance
    Hsiao, Yu-Yu
    Huang, Yi-Chia
    Chang, Sui-Yuan
    Kuo, Ching-Hua
    Chang, Shu-Fang
    Lin, Ya-Ting
    Luo, Yu-Zhen
    Lee, Yu-Lin
    Hung, Chien-Ching
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (04) : 755 - 757
  • [49] Pre-exposure prophylaxis to HIV in practice
    Buxeraud, Jacques
    ACTUALITES PHARMACEUTIQUES, 2016, 55 (554): : 8 - 8
  • [50] DISCOVER in Europe: a sub-analysis of the phase 3 randomized, controlled trial of daily emtricitabine/tenofovir alafenamide (F/TAF) or emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP)
    Post, F.
    Spinner, C.
    Coll, P.
    Hawkins, T.
    Anderson, J.
    Zhong, L.
    McCallister, S.
    HIV MEDICINE, 2019, 20 : 243 - 244
12345